Paying for On-Patent Pharmaceuticals

Paying for On-Patent Pharmaceuticals

In this article we propose a new approach to pricing for patent-protected (on-patent) pharmaceuticals. We describe and define limit pricing as a method for drug companies to maximize revenue for their investment by offering budget-neutral pricing to encourage early adoption by payers. Under this approach, payers are incentivized to adopt innovative but expensive drugs more quickly if drug compa...

Paying for outcomes: innovative coverage and reimbursement schemes for pharmaceuticals.

available at: http://www.ncbi.nlm.nih.gov/pubmed/12606142. Accessed September 25, 2009. 7. Baker LC, Atlas SW, Afendulis CC. Expanded use of imaging technology and the challenge of measuring value. Health Aff. (Millwood). 2008;27(6):1467-478. 8. Ridker PM, Danielson E, Fonseca FA, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 200...

Proposed trade agreement could increase patent protection for pharmaceuticals.

Patent Trolling: Why Bio & Pharmaceuticals Are at Risk

Patent trolls—also known variously as non-practicing entities, patent assertion entities, and patent monetizers—are a top priority on legislative and regulatory reform agendas. In modern debates, however, the biopharmaceutical industry goes conspicuously unmentioned. Although the biopharmaceutical industry is paradigmatically centered on patents, conventional wisdom holds that it is largely unt...

Paying more when paying for others.

Social behavior is heavily influenced by the perception of the behaviors of others. We considered how perceptions (and misperceptions) of kindness can increase generosity in economic transactions. We investigated how these perceptions can alter behavior in a novel real-life situation that pitted kindness against selfishness. That situation, consumer elective pricing, is defined by an economic t...